End-of-day quote
Other stock markets
|
||
- USD | - |
|
06-17 | TD Cowen Initiates Alkermes at Buy With $34 Price Target | MT |
06-11 | Transcript : Alkermes plc Presents at Goldman Sachs 45th Annual Global Healthcare Conference, Jun-11-2024 10:40 AM |
Sales 2024 * | 1.51B 2.06B | Sales 2025 * | 1.51B 2.06B | Capitalization | 4.08B 5.58B |
---|---|---|---|---|---|
Net income 2024 * | 338M 462M | Net income 2025 * | 342M 468M | EV / Sales 2024 * | 2.27 x |
Net cash position 2024 * | 663M 907M | Net cash position 2025 * | 1.03B 1.41B | EV / Sales 2025 * | 2.02 x |
P/E ratio 2024 * |
12.4
x | P/E ratio 2025 * |
12.2
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 95.07% |
Latest transcript on ALKERMES
Managers | Title | Age | Since |
---|---|---|---|
Richard Pops
CEO | Chief Executive Officer | 62 | 91-01-31 |
Blair Jackson
DFI | Director of Finance/CFO | 51 | 98-12-31 |
Shane Cooke
PSD | President | 61 | 11-08-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Richard Pops
CEO | Chief Executive Officer | 62 | 91-01-31 |
Nancy Snyderman
BRD | Director/Board Member | 72 | 16-05-25 |
Brian McKeon
BRD | Director/Board Member | 61 | 20-12-09 |
1st Jan change | Capi. | |
---|---|---|
+38.65% | 39.36B | |
-8.62% | 38.52B | |
+26.95% | 30.74B | |
+10.74% | 25.92B | |
-13.50% | 26.03B | |
+44.87% | 14.13B | |
+34.36% | 12.73B | |
-7.14% | 11.29B | |
-12.61% | 10.64B |